The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations

Cancer patients are susceptible groups to COVID-19, and risk-adjusted models show that most cancer patients have a 25–39% mortality risk if infected with COVID-19. The infection rate of SARS-CoV-2 in cancer patients in China was 0.79% (12 of 1524 patients; 95% CI, 0.31.2%). The case fatality rate of...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdihamid, Omar, Cai, Changjing, Kapesa, Linda, Zeng, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520115/
https://www.ncbi.nlm.nih.gov/pubmed/33061588
http://dx.doi.org/10.2147/CMAR.S272008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520115/
https://www.ncbi.nlm.nih.gov/pubmed/33061588
http://dx.doi.org/10.2147/CMAR.S272008

Ejemplares similares